Monopar Therapeutics liabilities 2020 to 2024

Statista2026-04-11 收录

生物制药分析

企业负债追踪

数据链接：

https://www.statista.com/statistics/1506796/monopar-therapeutics-liabilities/数据链接链接失效反馈

官方服务：

资源简介：

Liabilities of Monopar Therapeutics from 2020 to 2024 (in million U.S. dollars)

免疫组库数据分析

免疫组库

生物制药分析

本产品提供免疫组库全流程分析方案，涵盖BCR/TCR测序、单细胞免疫组库及多组学整合分析，包括TCR/BCR高变区序列注释、克隆多样性评估、高频克隆鉴定、体细胞超突变检测及基因重排特征解析、抗原特异性预测及克隆扩增动态监测、免疫细胞亚群精细分类、模型构建等内容，为肿瘤免疫治疗、自身免疫疾病及感染免疫研究提供关键数据支持，助力免疫治疗反应预测、疫苗效力评估、疾病机制解析及个性化治疗方案开发。

上海数据交易所2025-03-28 更新130

Etanercept glycoform assignment

生物制药分析

糖基化表征

ZIP archive containing raw spectra (in RAW and mzML format); MoFi parameter and output files; processed results and the corresponding processing scripts; glycopeptide data. See the readme file for fur

NIAID Data Ecosystem80

CD27 Antibody Market

抗体药物市场

生物制药分析

Report of CD27 Antibody Market is covering the summarized study of several factors encouraging the growth of the market such as market size, market type, major regions and end user applications. By us

IMR REPORTS50

Mustang Bio liabilities 2020 to 2024

生物制药分析

企业负债追踪

Liabilities of Mustang Bio from 2020 to 2024 (in million U.S. dollars)

Statista100

Lyell Immunopharma net cash 2020 to 2024

生物制药分析

现金流监控

Net cash of Lyell Immunopharma from 2020 to 2024 (in million U.S. dollars)

Statista60